{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:30:51Z","timestamp":1790292651136,"version":"4.1.0"},"reference-count":18,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>The purpose of this study was to identify the risk factors during the incident Clostridium difficile infection (CDI) episode, associated with developing recurrent CDI within 60 days, among hospitalized children that may be amenable to intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This was a retrospective cohort study of pediatric patients hospitalized at a freestanding children\u2019s hospital from January 1, 2003, to December 31, 2010. Patients were eligible if they were &amp;lt;18 years of age at admission and had a new diagnosis of CDI. Patients &amp;lt;1 year of age and those with a history of CDI in the previous 60 days were excluded. Age, gender, race, complex chronic conditions, and other information were collected. Multivariable logistic regression was used to evaluate predictors of recurrent CDI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>During the study period, there were 612 unique patients with an incident CDI episode; 65 (10.6%) experienced at least 1 recurrence. Patients with any complex chronic condition were 4.0 (95% confidence interval [CI]: 1.2\u201313.9) times more likely to experience recurrence. Patients with a malignancy and those who received non-CDI antibiotics at any time during CDI treatment were 2.3 (95% CI: 1.3\u20134.0) and 2.8 (95% CI: 1.2\u20136.9) times more likely to experience recurrence, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The presence of underlying comorbidities, malignancies, and treatment with non-CDI antibiotics during CDI treatment were the most important risk factors for recurrence. Efforts to reduce unnecessary courses of non-CDI antibiotics could lower the risk of CDI recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1542\/hpeds.2015-0170","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T04:46:37Z","timestamp":1464756397000},"page":"339-344","source":"Crossref","is-referenced-by-count":22,"title":["Risk Factors for Recurrent\n                    <i>Clostridium difficile<\/i>\n                    Infection in Pediatric Inpatients"],"prefix":"10.1542","volume":"6","author":[{"given":"Elyse M.","family":"Schwab","sequence":"first","affiliation":[{"name":"Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, Utah;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Wilkes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Primary Children\u2019s Hospital, Salt Lake City, Utah; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Korgenski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Primary Children\u2019s Hospital, Salt Lake City, Utah; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Hersh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Primary Children\u2019s Hospital, Salt Lake City, Utah; and"},{"name":"Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Pavia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Primary Children\u2019s Hospital, Salt Lake City, Utah; and"},{"name":"Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa W.","family":"Stevens","sequence":"additional","affiliation":[{"name":"Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, Utah;"},{"name":"Department of Pediatrics, Primary Children\u2019s Hospital, Salt Lake City, Utah; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"2021120817464305600_B1","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1093\/clinids\/18.Supplement_4.S265","article-title":"Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism","volume":"18","author":"Bartlett","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2021120817464305600_B2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/659156","article-title":"Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals","volume":"32","author":"Miller","year":"2011","journal-title":"Infection Control & Hospital Epidemiology"},{"issue":"6","key":"2021120817464305600_B3","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1542\/peds.2008-0469","article-title":"Epidemiological features of Clostridium difficile\u2013associated disease among inpatients at children\u2019s hospitals in the United States, 2001\u20132006","volume":"122","author":"Kim","year":"2008","journal-title":"Pediatrics"},{"issue":"5","key":"2021120817464305600_B4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archpediatrics.2010.282","article-title":"Clostridium difficile infection in hospitalized children in the United States","volume":"165","author":"Nylund","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021120817464305600_B5","volume-title":"Mandell, Douglas and Bennett\u2019s principles and practice of infectious diseases","author":"Mandell","year":"1995","edition":"4th ed."},{"issue":"4","key":"2021120817464305600_B6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/INF.0000000000000108","article-title":"Predictors of first recurrence of Clostridium difficile infections in children","volume":"33","author":"Tschudin-Sutter","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"2021120817464305600_B7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/cid\/cit075","article-title":"The epidemiology of Clostridium difficile infection in children: a population-based study","volume":"56","author":"Khanna","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2021120817464305600_B8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/INF.0b013e3182352e2c","article-title":"Risk factors and outcomes associated with severe Clostridium difficile infection in children","volume":"31","author":"Kim","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"2021120817464305600_B9","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000000553","article-title":"Novel risk factors for recurrent Clostridium difficile infection in children","author":"Nicholson","year":"2015;60(1):18\u201322","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"2021120817464305600_B10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/clinids\/24.3.324","article-title":"Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial","volume":"24","author":"Fekety","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2021120817464305600_B11","doi-asserted-by":"crossref","first-page":"e98400","DOI":"10.1371\/journal.pone.0098400","article-title":"Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review","volume":"9","author":"Abou Chakra","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2021120817464305600_B12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhin.2008.08.012","article-title":"Meta-analysis to assess risk factors for recurrent Clostridium difficile infection","volume":"70","author":"Garey","year":"2008","journal-title":"J Hosp Infect"},{"issue":"1 pt 2","key":"2021120817464305600_B13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1542\/peds.106.S1.205","article-title":"Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980\u20131997","volume":"106","author":"Feudtner","year":"2000","journal-title":"Pediatrics"},{"issue":"7","key":"2021120817464305600_B14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"2021120817464305600_B15","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/INF.0b013e3182027c22","article-title":"Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool","volume":"30","author":"Shaklee","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2021120817464305600_B16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1081\/QEN-120001878","article-title":"Model-dependent variance inflation factor cutoff values","volume":"14","author":"Craney","year":"2002","journal-title":"Qual Eng"},{"issue":"5","key":"2021120817464305600_B17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infection Control & Hospital Epidemiology"},{"issue":"1","key":"2021120817464305600_B18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cid\/cis840","article-title":"Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program","volume":"56","author":"Longtin","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/6\/6\/339\/813845\/hpeds_2015-0170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/6\/6\/339\/813845\/hpeds_2015-0170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T18:44:11Z","timestamp":1656614651000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/6\/6\/339\/26357\/Risk-Factors-for-Recurrent-Clostridium-difficile"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,1]]},"published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2015-0170","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726336382.793526587","asserted-by":"object"}]},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}